Annual Accounts Receivable
$357.00 K
+$9000.00+2.59%
31 December 2023
Summary:
Evogene annual accounts receivable is currently $357.00 thousand, with the most recent change of +$9000.00 (+2.59%) on 31 December 2023. During the last 3 years, it has risen by +$135.00 thousand (+60.81%). EVGN annual accounts receivable is now -86.65% below its all-time high of $2.67 million, reached on 31 December 2015.EVGN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$1.59 M
+$1.21 M+322.87%
01 September 2024
Summary:
Evogene quarterly accounts receivable is currently $1.59 million, with the most recent change of +$1.21 million (+322.87%) on 01 September 2024. Over the past year, it has increased by +$245.00 thousand (+18.22%). EVGN quarterly accounts receivable is now -40.56% below its all-time high of $2.67 million, reached on 31 December 2015.EVGN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVGN Accounts Receivable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +2.6% | +18.2% |
3 y3 years | +60.8% | +953.0% |
5 y5 years | +123.1% | +981.6% |
EVGN Accounts Receivable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +60.8% | at high | +1332.4% |
5 y | 5 years | at high | +395.8% | at high | +4576.5% |
alltime | all time | -86.7% | +395.8% | -40.6% | +4576.5% |
Evogene Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.59 M(+322.9%) |
June 2024 | - | $376.00 K(-30.2%) |
Mar 2024 | - | $539.00 K(+51.0%) |
Dec 2023 | $357.00 K(+2.6%) | $357.00 K(-73.5%) |
Sept 2023 | - | $1.34 M(+655.6%) |
June 2023 | - | $178.00 K(-28.8%) |
Mar 2023 | - | $250.00 K(-28.2%) |
Dec 2022 | $348.00 K(+23.8%) | $348.00 K(-23.0%) |
Sept 2022 | - | $452.00 K(+307.2%) |
June 2022 | - | $111.00 K(-33.1%) |
Mar 2022 | - | $166.00 K(-40.9%) |
Dec 2021 | $281.00 K(+26.6%) | $281.00 K(+86.1%) |
Sept 2021 | - | $151.00 K(-27.4%) |
June 2021 | - | $208.00 K(-5.0%) |
Mar 2021 | - | $219.00 K(-1.4%) |
Dec 2020 | $222.00 K(+208.3%) | $222.00 K(+552.9%) |
Sept 2020 | - | $34.00 K(-42.4%) |
June 2020 | - | $59.00 K(-3.3%) |
Mar 2020 | - | $61.00 K(-15.3%) |
Dec 2019 | $72.00 K(-55.0%) | $72.00 K(-51.0%) |
Sept 2019 | - | $147.00 K(0.0%) |
June 2019 | - | $147.00 K(+286.8%) |
Mar 2019 | - | $38.00 K(-76.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | $160.00 K(+21.2%) | $160.00 K(-32.2%) |
Sept 2018 | - | $236.00 K(+82.9%) |
June 2018 | - | $129.00 K(-31.7%) |
Mar 2018 | - | $189.00 K(+43.2%) |
Dec 2017 | $132.00 K(-21.9%) | $132.00 K(-86.4%) |
Sept 2017 | - | $968.00 K(-8.9%) |
June 2017 | - | $1.06 M(+70.1%) |
Mar 2017 | - | $625.00 K(+269.8%) |
Dec 2016 | $169.00 K(-93.7%) | $169.00 K(+69.0%) |
Sept 2016 | - | $100.00 K(+25.0%) |
June 2016 | - | $80.00 K(-87.2%) |
Mar 2016 | - | $625.00 K(-76.6%) |
Dec 2015 | $2.67 M(+126.1%) | $2.67 M(+177.8%) |
Sept 2015 | - | $963.00 K(+28.4%) |
June 2015 | - | $750.00 K(-8.1%) |
Mar 2015 | - | $816.00 K(-31.0%) |
Dec 2014 | $1.18 M(-38.2%) | $1.18 M(+7.3%) |
Sept 2014 | - | $1.10 M(-40.8%) |
June 2014 | - | $1.86 M(-0.6%) |
Mar 2014 | - | $1.88 M(-1.9%) |
Dec 2013 | $1.91 M(+24.1%) | $1.91 M(+4.2%) |
Sept 2013 | - | $1.84 M(-0.9%) |
June 2013 | - | $1.85 M(+20.2%) |
Dec 2012 | $1.54 M | $1.54 M |
FAQ
- What is Evogene annual accounts receivable?
- What is the all time high annual accounts receivable for Evogene?
- What is Evogene annual accounts receivable year-on-year change?
- What is Evogene quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Evogene?
- What is Evogene quarterly accounts receivable year-on-year change?
What is Evogene annual accounts receivable?
The current annual accounts receivable of EVGN is $357.00 K
What is the all time high annual accounts receivable for Evogene?
Evogene all-time high annual accounts receivable is $2.67 M
What is Evogene annual accounts receivable year-on-year change?
Over the past year, EVGN annual accounts receivable has changed by +$9000.00 (+2.59%)
What is Evogene quarterly accounts receivable?
The current quarterly accounts receivable of EVGN is $1.59 M
What is the all time high quarterly accounts receivable for Evogene?
Evogene all-time high quarterly accounts receivable is $2.67 M
What is Evogene quarterly accounts receivable year-on-year change?
Over the past year, EVGN quarterly accounts receivable has changed by +$245.00 K (+18.22%)